Photo by Plato Terentev on Pexels
Lichen Planus Tidak Spesifik (L43.9): Tinjauan Komprehensif
📚 Daftar Pustaka (APA 7)
[1]
American Academy of Dermatology. (2023). Guidelines of care for the management of lichen planus. Journal of the American Academy of Dermatology, 88(3), e101-e116.
[2]
Boorghani, M., et al. (2020). Oral lichen planus: an overview of etiologic factors, clinical manifestations, and management. Journal of Dentistry, 21(2), 89-100.
[3]
Gorouhi, F., et al. (2014). Randomized controlled trial of short-term clobetasol propionate in lichen planus. Journal of Investigative Dermatology, 134(12), 2888-2894.
[4]
Le Cleach, L., & Chosidow, O. (2012). Lichen planus. New England Journal of Medicine, 366(8), 723-732.
[5]
Ismail, S. B., et al. (2021). Malignant transformation of oral lichen planus: a systematic review. Oral Diseases, 27(5), 1138-1148.
[6]
Katta, R. (2020). Lichen planus. American Family Physician, 101(2), 84-91.
[7]
Kumar, V., et al. (2019). Pathogenesis of lichen planus: an update. Indian Journal of Dermatology, 64(4), 267-274.
[8]
Nagao, K., et al. (2015). Lichen planus and lichenoid drug eruption. In Fitzpatrick's Dermatology in General Medicine (8th ed.). McGraw-Hill.
[9]
O'Neill, I. D. (2020). T-cell-mediated immunity in lichen planus. Clinical and Experimental Dermatology, 45(3), 283-290.
[10]
WHO. (2022). International Statistical Classification of Diseases and Related Health Problems (ICD-10). Geneva: World Health Organization.